07:33:03 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-11-13 Kvartalsrapport 2024-Q3
2024-08-27 Kvartalsrapport 2024-Q2
2024-05-08 Kvartalsrapport 2024-Q1
2024-05-02 Ordinarie utdelning LIFE 0.00 NOK
2024-04-30 Årsstämma 2024
2024-02-27 Bokslutskommuniké 2023
2023-11-14 Kvartalsrapport 2023-Q3
2023-08-23 Kvartalsrapport 2023-Q2
2023-05-11 Kvartalsrapport 2023-Q1
2023-05-08 Ordinarie utdelning LIFE 0.00 NOK
2023-04-18 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-09 Ordinarie utdelning LIFE 0.00 NOK
2022-05-06 Årsstämma 2022
2022-04-21 Bokslutskommuniké 2021
2021-09-30 Extra Bolagsstämma 2021
2021-08-05 Kvartalsrapport 2021-Q2
2021-05-10 Ordinarie utdelning LIFE 0.00 NOK
2021-05-07 Årsstämma 2021
2021-04-20 Bokslutskommuniké 2020
2020-06-26 Årsstämma 2020
2020-06-01 Bokslutskommuniké 2019
2019-02-07 Split LIFE 4:1
2018-12-11 Extra Bolagsstämma 2018

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
Lifecare är ett norskt bolag verksamma inom medicinteknik. Idag är bolaget specialiserade inom forskning och utveckling av diabetes. Produkterna är patenterade och används som glukosgivare. Mikrosensorerna injiceras under huden på patientens handled, och fungerar vidare som en realtidsuppdatering av glukosnivån i patienten. Utöver bidrar tekniken med larmsensor samt tillgång till historisk data över patientens glukosnivå. Bolaget etablerades under 2006 och har sitt huvudkontor i Bergen, Norge.
2023-12-19 08:00:00

Professor Dr. Tony James will join Lifecare's Scientific Advisory Board. - We have collaborated with Professor Tony James since 2019, and we are really excited to bring him on board in this position, says CEO Joacim Holter.

Tony James is professor of Chemistry at the University of Bath and Fellow of the Royal Society of Chemistry. He has received the Daiwa-Adrian Prize for developing scientific links with Japan, the CASE Prize for establishing scientific networks with China, the MSMLG Czarnik Award, the Frontiers in Chemistry Diversity Award and a Royal Society Wolfson Research Merit Award. He is also listed by Clarivate as a Highly Cited Researcher in Chemistry.

– Tony James has an outstanding academic record. He has published over 470 publications, including three books, 10 book chapters and 457 papers in international peer reviewed journals. Professor James is also the named inventor on 30 international patents and has delivered 266 invited lectures within the UK and internationally. He is a remarkable asset for Lifecare, Holter points out.

The CEO of Lifecare states that he is very pleased that Prof James will now add valuable insight within his area of expertise to our highly competent Scientific Advisory Board.

Lifecare's Scientific Advisory Board is chaired by the distinguished Prof. David C. Klonoff: https://lifecare.no/about-lifecare/#scientificadv